Almitas Capital »

Nektar Therapeutics shares owned by Almitas Capital

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by Almitas Capital from 13F filings

Historical chart of Almitas Capital investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by Almitas Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by Almitas Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $860k 920k 0.93

More positions owned by Almitas Capital

Great Ajax Corp 7.25 CV SR NT 24 (AJXA)
Nuveen Core Plus Impact Fund Com Ben Int (NPCT)
BlackRock Health Sciences Term Trust Com Shs (BMEZ)
Nuveen PA Investnt Quality Municipal (NQP)
Miller/Howard High Dividend Fund Com Shs Ben In (HIE)
BlackRock ESG Capital Allocation Term Trust Shs Ben Int (ECAT)
Eaton Vance New York Municipal Bond Fund (ENX)
First Tr Energy Infrastrctr (FIF)
Pgim Short Dur Hig Yld Opp F (SDHY)
PIMCO Energy & Tactical Credit Opportunities Fund Com Shs Ben Int (PDX)
First Trust Energy Income & Gr (FEN)
BlackRock California Municipal Income Trust Sh Ben Int (BFZ)
Nuveen Preferred And equity (JPI)
Tortoise Midstream Energy M (NTG)
Great Ajax Corp reit (AJX)

View all positions for Almitas Capital

Top funds holding Nektar Therapeutics

Vanguard Group
Acadian Asset Management
PRIMECAP Management Company
BlackRock
Monaco Asset Management SAM
Citadel Advisors
Millennium Management
D. E. Shaw & Co
Nantahala Capital Management
Two Sigma Advisers
Two Sigma Investments
Shay Capital
Lynx1 Capital Management
Geode Capital Management
GSA Capital Partners

View all funds holding Nektar Therapeutics